10-71511238-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022124.6(CDH23):​c.429+26A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 1,601,118 control chromosomes in the GnomAD database, including 363,819 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 41854 hom., cov: 33)
Exomes 𝑓: 0.66 ( 321965 hom. )

Consequence

CDH23
NM_022124.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.23

Publications

11 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23-AS1 (HGNC:31433): (CDH23 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 10-71511238-A-G is Benign according to our data. Variant chr10-71511238-A-G is described in ClinVar as Benign. ClinVar VariationId is 261548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.429+26A>G intron_variant Intron 6 of 69 ENST00000224721.12 NP_071407.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.429+26A>G intron_variant Intron 6 of 69 5 NM_022124.6 ENSP00000224721.9

Frequencies

GnomAD3 genomes
AF:
0.731
AC:
110878
AN:
151734
Hom.:
41808
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.920
Gnomad AMI
AF:
0.492
Gnomad AMR
AF:
0.578
Gnomad ASJ
AF:
0.734
Gnomad EAS
AF:
0.777
Gnomad SAS
AF:
0.596
Gnomad FIN
AF:
0.746
Gnomad MID
AF:
0.637
Gnomad NFE
AF:
0.658
Gnomad OTH
AF:
0.699
GnomAD2 exomes
AF:
0.660
AC:
164324
AN:
248910
AF XY:
0.659
show subpopulations
Gnomad AFR exome
AF:
0.930
Gnomad AMR exome
AF:
0.457
Gnomad ASJ exome
AF:
0.733
Gnomad EAS exome
AF:
0.778
Gnomad FIN exome
AF:
0.733
Gnomad NFE exome
AF:
0.662
Gnomad OTH exome
AF:
0.659
GnomAD4 exome
AF:
0.663
AC:
961402
AN:
1449264
Hom.:
321965
Cov.:
29
AF XY:
0.662
AC XY:
477697
AN XY:
721822
show subpopulations
African (AFR)
AF:
0.934
AC:
31054
AN:
33236
American (AMR)
AF:
0.467
AC:
20885
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.728
AC:
18957
AN:
26044
East Asian (EAS)
AF:
0.758
AC:
30052
AN:
39636
South Asian (SAS)
AF:
0.606
AC:
52154
AN:
85994
European-Finnish (FIN)
AF:
0.726
AC:
38654
AN:
53266
Middle Eastern (MID)
AF:
0.700
AC:
4021
AN:
5748
European-Non Finnish (NFE)
AF:
0.658
AC:
724702
AN:
1100696
Other (OTH)
AF:
0.683
AC:
40923
AN:
59948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
14551
29102
43652
58203
72754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18856
37712
56568
75424
94280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.731
AC:
110976
AN:
151854
Hom.:
41854
Cov.:
33
AF XY:
0.730
AC XY:
54194
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.920
AC:
38165
AN:
41468
American (AMR)
AF:
0.577
AC:
8810
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.734
AC:
2547
AN:
3468
East Asian (EAS)
AF:
0.777
AC:
4006
AN:
5156
South Asian (SAS)
AF:
0.597
AC:
2872
AN:
4814
European-Finnish (FIN)
AF:
0.746
AC:
7839
AN:
10510
Middle Eastern (MID)
AF:
0.640
AC:
187
AN:
292
European-Non Finnish (NFE)
AF:
0.658
AC:
44634
AN:
67854
Other (OTH)
AF:
0.695
AC:
1468
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1443
2886
4328
5771
7214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
834
1668
2502
3336
4170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.701
Hom.:
9594
Bravo
AF:
0.724
Asia WGS
AF:
0.681
AC:
2370
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1D Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 12 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.41
DANN
Benign
0.48
PhyloP100
-1.2
PromoterAI
-0.0033
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3802718; hg19: chr10-73270995; API